Golub Capital Increases Risk Strategies Unitranche to $4.45 Billion
The latest
Golub Capital helped the borrower achieve an optimal result by agreeing to hold a meaningful portion of the incremental loan, adding to its already significant position in the credit and leading a robust syndication process for the remainder. The Firm generated an oversubscribed book, allowing the transaction to be upsized from
"The unitranche market is open and private equity players value the scalability offered by unitranche facilities for their buy-and-build strategies," said
Golub Capital started its relationship with Risk Strategies in 2015, when it was a
"Golub Capital has consistently been a reliable financing partner, providing the balance sheet capabilities and capital markets expertise that continues to support Risk Strategies' growth," said
About Golub Capital Sponsor Finance
Golub Capital is a market-leading, award-winning direct lender and experienced credit asset manager. We specialize in delivering reliable, creative and compelling financing solutions to companies backed by private equity sponsors. The firm's Direct Lending group provides buy-and-hold financing for sponsor-backed transactions with hold positions up to
As of
About Risk Strategies
Risk Strategies is the 9th largest privately held US brokerage firm offering comprehensive risk management advice, insurance and reinsurance placement for property & casualty, employee benefits, private client services, as well as consulting services and financial & wealth solutions. With more than 30 specialty practices, Risk Strategies serves commercial companies, nonprofits, public entities, and individuals, and has access to all major insurance markets. Risk Strategies has over 100 offices including
About Kelso & Company
Kelso & Company is one of the oldest and most established firms specializing in private equity investing. Since 1980, Kelso has invested approximately
Media Contact
View original content to download multimedia:https://www.prnewswire.com/news-releases/golub-capital-increases-risk-strategies-unitranche-to-4-45-billion-301906135.html
SOURCE Golub Capital
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
- Benz Announces A$150m Placement to Accelerate Delivery of Glenburgh Maiden Resource
- Appointment of Non-Executive Directors
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Golub CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share